Peroxisome Proliferator‐Activated Receptors: New Players in the Field of Reproduction

Bettina Tóth, Daniela Hornung, Christoph Scholz, Schima Djalali, Klaus Friese, Udo JeschkeAmerican 2007 · DOI

Abstract

Peroxisome proliferator-activated receptors (PPAR) are members of the nuclear hormone receptor superfamily. Synthetic ligands to one family member, PPARgamma, are currently widely used as treatment for chronic diseases such as diabetes type II and other insulin resistances, e.g. as seen in polycystic ovary syndrome (PCOS). Moreover, novel approaches employing knock-out mice demonstrated that PPARgamma seems to play a key role in placental and fetal development. This review describes recent insights into the role of PPARs in human reproduction with specific reference to infertility, placental maturation and fetal development as well as disturbed pregnancy. Further, we highlight the current knowledge on synthetic ligands to PPARgamma used as a treatment in women with PCOS.
BibTeX
@inproceedings{toth2007peroxisome,
  author = {Bettina Tóth and Daniela Hornung and Christoph Scholz and Schima Djalali and Klaus Friese and Udo Jeschke},
  title = {{Peroxisome Proliferator‐Activated Receptors: New Players in the Field of Reproduction}},
  booktitle = {American},
  year = {2007},
  doi = {10.1111/j.1600-0897.2007.00514.x},
}

Loading related content...

Figure